Evidence map›Paper›PMID 40699857›Full record

ArticleCurrent issues in molecular biology2025

HLA-DRB1 and DQB1 Allelic Polymorphism and Multiple Sclerosis in a Moroccan Population.

Abir Fguirouche, Yahya Naji, Morad Guennouni, Raja Hazime, Safa Zahlane, Mohamed Chraa, Najib Kissani, Nissrine Louhab, Brahim Admou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current issues in molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Abir FguiroucheLaboratory of Immunology and HLA, Center of Clinical Research, Mohammed VI University Hospital, Marrakech 40080, Morocco.ORCID 0000-0003-0783-1344
Yahya NajiNeurology Department, Faculty of Medicine and Pharmacy, University Hospital of Agadir, Ibn Zohr University, Agadir 80060, Morocco.ORCID 0000-0001-6496-3613
Morad GuennouniScience and Technology Team, Higher School of Education and Training, Chouaib Doukkali University, El Jadida 24000, Morocco.ORCID 0000-0002-3963-1366
Raja HazimeLaboratory of Immunology and HLA, Center of Clinical Research, Mohammed VI University Hospital, Marrakech 40080, Morocco.
Safa ZahlaneNeurology Department, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech 40080, Morocco.
Mohamed ChraaNeurology Department, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech 40080, Morocco.
Najib KissaniNeurology Department, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech 40080, Morocco.
Nissrine LouhabNeurology Department, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech 40080, Morocco.
Brahim AdmouLaboratory of Immunology and HLA, Center of Clinical Research, Mohammed VI University Hospital, Marrakech 40080, Morocco.ORCID 0000-0003-3255-8220

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

genetic susceptibilityHLA-DQB1HLA-DRB1Moroccan populationmultiple sclerosis

Identifiers

PMID40699857
PMCPMC12191977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.